
- February 1, 2024
- Commentary
Veripath R & UR Funds Q4 2023 – NAVs, fund metrics View full report
Read more...
- December 18, 2023
- Commentary
Veripath R & UR Funds Q3 2023 – NAVs, fund metrics View full report
Read more...
- November 9, 2023
- Commentary
Veripath continues to generate compelling risk-adjusted returns and a recent $60M acquisition of irrigated land in Alberta brings total assets under management (AUM) to over $350M
Read more...
- September 19, 2023
- Commentary
We are pleased to present the report to unitholders for the quarter ended June 30, 2023.
Read more...
- August 12, 2023
- Commentary
Veripath’s investors have confidence that our non-operated farmland thesis rests on a foundation of well researched elements.
Read more...
Update on the portfolio operating partneship strategy - Averine (royalties), Corpus (healthcare) and Preceptos (light industrial).
Read more...
Veripath Fact Sheet Q4 2022 – Check the complete report below View full report
Read more...
Q1 2023 Newsletter – Canadian farm productivity will be positively impacted by global warming – Check the complete report below View full report
Read more...
- February 7, 2023
- Commentary
Veripath Fact Sheet Q4 2022 – Check the complete report below View full report
Read more...